Why HIV Virions Have Low Numbers of Envelope Spikes: Implications for Vaccine Development

Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy

(2014) Anthony P. West et al.   CELL

Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model

(2014) Bryce Chackerian et al.   JOURNAL OF IMMUNOLOGY

Autoreactivity in HIV-1 broadly neutralizing antibodies

(2014) Laurent Verkoczy et al.   Current Opinion in HIV and AIDS

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

(2013) M. Safaeian et al.   Cancer Prevention Research

HIV-1 neutralizing antibodies: understanding nature's pathways

(2013) John R. Mascola et al.   IMMUNOLOGICAL REVIEWS

Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies

(2013) Guang Yang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Active immunotherapy for chronic diseases

(2013) Martin F. Bachmann et al.   VACCINE

Understanding and learning from the success of prophylactic human papillomavirus vaccines

(2012) John T. Schiller et al.   NATURE REVIEWS MICROBIOLOGY

Molecular underpinning of B-cell anergy

(2010) Yuval Yarkoni et al.   IMMUNOLOGICAL REVIEWS

Few and Far Between: How HIV May Be Evading Antibody Avidity

(2010) Joshua S. Klein et al.   PLoS Pathogens

HPV - immune response to infection and vaccination

(2010) Margaret Stanley   Infectious Agents and Cancer

Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis

(2008) Kimberly A Powers et al.   LANCET INFECTIOUS DISEASES